Nyrada Inc. (NYR.AX)

AUD 0.1

(-4.76%)

Revenue Summary of Nyrada Inc.

  • Nyrada Inc.'s latest annual revenue in 2024 was - AUD , down -100.0% from previous year.
  • Nyrada Inc.'s latest quarterly revenue in 2024 FY was - AUD , down -100.0% from previous quarter.
  • Nyrada Inc. reported a annual revenue of 1.42 Million AUD in annual revenue 2023, up 30.73% from previous year.
  • Nyrada Inc. reported a annual revenue of 1.09 Million AUD in annual revenue 2022, down -53.18% from previous year.
  • Nyrada Inc. reported a quarterly revenue of - AUD for 2024 FY, down -100.0% from previous quarter.
  • Nyrada Inc. reported a quarterly revenue of 2.45 Million AUD for 2024 Q2, down 0.0% from previous quarter.

Annual Revenue Chart of Nyrada Inc. (2024 - 2018)

Historical Annual Revenue of Nyrada Inc. (2024 - 2018)

Year Revenue Revenue Growth
2024 - AUD -100.0%
2023 1.42 Million AUD 30.73%
2022 1.09 Million AUD -53.18%
2021 2.33 Million AUD 107.57%
2020 1.12 Million AUD 131.41%
2019 486.33 Thousand AUD 0.0%
2018 - AUD 0.0%

Peer Revenue Comparison of Nyrada Inc.

Name Revenue Revenue Difference
AdAlta Limited 1.73 Million AUD 100.0%
Acrux Limited 5.09 Million AUD 100.0%
Actinogen Medical Limited 9.93 Million AUD 100.0%
AnteoTech Limited 460.39 Thousand AUD 100.0%
Argenica Therapeutics Limited 2.59 Million AUD 100.0%
Arovella Therapeutics Limited 17 Thousand AUD 100.0%
Anatara Lifesciences Ltd - AUD NaN%
Alterity Therapeutics Limited 4.01 Million AUD 100.0%
Amplia Therapeutics Limited 4.45 Million AUD 100.0%
Avecho Biotechnology Limited 473.55 Thousand AUD 100.0%
Bio-Gene Technology Limited 18.32 Thousand AUD 100.0%
Biome Australia Limited 13 Million AUD 100.0%
Biotron Limited - AUD NaN%
Botanix Pharmaceuticals Limited 601.82 Thousand AUD 100.0%
BTC Health Limited 16.36 Thousand AUD 100.0%
Chimeric Therapeutics Limited 7.45 Million AUD 100.0%
CSL Limited 22.41 Billion AUD 100.0%
Clarity Pharmaceuticals Ltd 11.5 Million AUD 100.0%
Clinuvel Pharmaceuticals Limited 88.17 Million AUD 100.0%
Cynata Therapeutics Limited 2.31 Million AUD 100.0%
Dimerix Limited 583.47 Thousand AUD 100.0%
EZZ Life Science Holdings Limited 66.44 Million AUD 100.0%
Hexima Limited - AUD NaN%
Island Pharmaceuticals Limited 1.25 Million AUD 100.0%
Immuron Limited 4.9 Million AUD 100.0%
Immutep Limited 3.5 Million AUD 100.0%
Imugene Limited - AUD NaN%
Invex Therapeutics Ltd 1.21 Million AUD 100.0%
Memphasys Limited 60 Thousand AUD 100.0%
Nanollose Limited 12.5 Thousand AUD 100.0%
Neuren Pharmaceuticals Limited 231.92 Million AUD 100.0%
Noxopharm Limited 2.4 Million AUD 100.0%
NeuroScientific Biopharmaceuticals Limited - AUD NaN%
Orthocell Limited 5.31 Million AUD 100.0%
PharmAust Limited - AUD NaN%
Patrys Limited 1.39 Million AUD 100.0%
Paradigm Biopharmaceuticals Limited 65.8 Thousand AUD 100.0%
Proteomics International Laboratories Limited 892.14 Thousand AUD 100.0%
Prescient Therapeutics Limited 3.71 Million AUD 100.0%
PYC Therapeutics Limited 22.05 Million AUD 100.0%
Race Oncology Limited 4 Million AUD 100.0%
Radiopharm Theranostics Limited 299.22 Thousand AUD 100.0%
Recce Pharmaceuticals Ltd - AUD NaN%
Starpharma Holdings Limited 8.28 Million AUD 100.0%
Telix Pharmaceuticals Limited 496.65 Million AUD 100.0%
Tissue Repair Ltd 152.24 Thousand AUD 100.0%
Zelira Therapeutics Limited 94.95 Thousand AUD 100.0%